These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 696019)

  • 41. [Glomerulonephritis in rheumatoid arthritis].
    Khamishon LZ; Chichasova NV; Kanevskaia MZ; Varshavskiĭ VA; Semeĭkina OV; Krel' AA; Severgina ES
    Revmatologiia (Mosk); 1989; (4):18-23. PubMed ID: 2637460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early diagnosis and treatment of chronic glomerulonephritis].
    Kinoshita Y; Osawa G; Mikami A; Morita T; Kobayashi N
    Naika; 1969 Jun; 23(6):1190-201. PubMed ID: 5805493
    [No Abstract]   [Full Text] [Related]  

  • 43. [Course and prognosis of glomerulonephritis].
    Cagli V
    Policlinico Prat; 1970 Oct; 77(40):1271-86. PubMed ID: 4920756
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of renoparenchymal hypertension in chronic glomerulonephritis with normal and impaired renal function].
    Stefanov G; Tishkov I; Todorova L
    Vutr Boles; 1982; 21(5):49-53. PubMed ID: 7164406
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of mineral water from the Naftusia spa of the Truskavets health resort on the functional state of the kidneys in chronic diffuse glomerulonephritis].
    Dudchenko MA; Andreeva ME; Chuenko AE; Dudchenko AM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):529-31. PubMed ID: 5317697
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparative evaluation of the clinical course and dynamics of the morphological changes in chronic glomerulonephritis].
    Tov NL; Valentik MF; Vlazneva VA; Kagalovskaia IM; Nesina IA
    Ter Arkh; 1986; 58(8):10-3. PubMed ID: 3764748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Features of the course of chronic glomerulonephritis with respect to age].
    Grinbaum NB; Ar'eva EM
    Klin Med (Mosk); 1972 Jun; 50(6):66-70. PubMed ID: 5086281
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prognostic standard in chronic glomerulonephritis-clinical observation and the kidney function].
    Urakabe S; Orita Y; Ando A; Fukuhara Y; Abe H
    Nihon Rinsho; 1974 Oct; 32(10):3102-6. PubMed ID: 4475169
    [No Abstract]   [Full Text] [Related]  

  • 49. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
    Mathew TH; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):727-34. PubMed ID: 4803314
    [No Abstract]   [Full Text] [Related]  

  • 50. [Primary chronic glomerulonephritis].
    Pygiz LA; Mel'man NIa
    Klin Med (Mosk); 1979 Jul; 57(7):76-81. PubMed ID: 480889
    [No Abstract]   [Full Text] [Related]  

  • 51. [Renal functions in inflammatory kidney diseases].
    Ratner MY; Brodskiĭ MA; Schultze BD; Prächt K; Hagemann J
    Klin Med (Mosk); 1985 Jan; 63(1):82-6. PubMed ID: 3990194
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pregnancy in women with nephrotic syndrome in chronic glomerulonephritis].
    Wielgosz A; Zdrojewski Z
    Pol Tyg Lek; 1984 Oct 1-8; 39(40-41):1309-11. PubMed ID: 6514599
    [No Abstract]   [Full Text] [Related]  

  • 53. [Quantitative comprehension and evaluation of laboratory data in chronic diseases, presented on the example of glomerulonephritis].
    Reinschke P; Reinschke K
    Z Urol Nephrol; 1973 Sep; 66(9):641-53. PubMed ID: 4782786
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinico-laboratory pattern and effectiveness of glucocorticoid therapy of patients with primary diffuse mesangioproliferative glomerulonephritis].
    Diadyk AI; Dikshteĭn EA; Vasilenko IV; Siniachenko OV; Kobets VG
    Ter Arkh; 1987; 59(8):35-7. PubMed ID: 3686443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Incidence and characteristics of the hypertension syndrome in chronic glomerulonephritis].
    Stefanov G; Tishkov I; Todorova L
    Vutr Boles; 1982; 21(5):53-8. PubMed ID: 7164407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [On the effect of 1-aminoadamantane hydrochloride on the kidney function].
    Gessler U
    Arzneimittelforschung; 1968 Feb; 18(2):221-2. PubMed ID: 5695383
    [No Abstract]   [Full Text] [Related]  

  • 57. [The course of chronic glomerulonephritis and pyelonephritis in pregnant women].
    Mel'man NIa; Pyrig LA; Cherniakova IA; Taran EI
    Vrach Delo; 1988 Aug; (8):27-30. PubMed ID: 3206878
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term prognosis of malignant hypertension; difference between underlying diseases such as essential hypertension and chronic glomerulonephritis.
    Kawazoe N; Eto T; Abe I; Takishita S; Ueno M; Kobayashi K; Uezono K; Muratani H; Kimura Y; Tomita Y
    Clin Nephrol; 1988 Feb; 29(2):53-7. PubMed ID: 3359695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The importance of the clinical classification of chronic glomerulonephritis for the prognosis of its progression and of the efficacy of therapy].
    Ratner MIa; Serov VV; Stenina IN; Fedorova ND; Shumakov VI
    Ter Arkh; 1996; 68(6):10-3. PubMed ID: 8771673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sanatorium treatment of patients with chronic glomerulonephritis (without disorder of the nitrogen excretory function of the kidneys) on the Crimean South Shore].
    Pyrig LA; Ratner ZG; Kropacheva NA; Vinnikova FIa; Oleĭnikov PD; Povetkin SV
    Vrach Delo; 1968 Jul; 7():44-7. PubMed ID: 4245750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.